OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, et al.
Therapeutic Advances in Neurological Disorders (2020) Vol. 13, pp. 175628642096950-175628642096950
Open Access | Times Cited: 13
Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, et al.
Therapeutic Advances in Neurological Disorders (2020) Vol. 13, pp. 175628642096950-175628642096950
Open Access | Times Cited: 13
Showing 13 citing articles:
Polypharmacy and multiple sclerosis: A population-based study
Aníbal Chertcoff, Huah Shin Ng, Feng Zhu, et al.
Multiple Sclerosis Journal (2022) Vol. 29, Iss. 1, pp. 107-118
Open Access | Times Cited: 21
Aníbal Chertcoff, Huah Shin Ng, Feng Zhu, et al.
Multiple Sclerosis Journal (2022) Vol. 29, Iss. 1, pp. 107-118
Open Access | Times Cited: 21
Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
Michael Hecker, Niklas Frahm, Paula Bachmann, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Michael Hecker, Niklas Frahm, Paula Bachmann, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
The Use of Multiple Medications During Pregnancy Among an Ethnically Diverse Population in South-Eastern Melbourne: A Retrospective Analysis to Explore Potential Risks and Complications
Yitayeh Belsti, Aya Mousa, Hannah Jackson, et al.
Drug Safety (2024)
Open Access | Times Cited: 3
Yitayeh Belsti, Aya Mousa, Hannah Jackson, et al.
Drug Safety (2024)
Open Access | Times Cited: 3
Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
Paula Bachmann, Niklas Frahm, Jane Louisa Debus, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 592-592
Open Access | Times Cited: 14
Paula Bachmann, Niklas Frahm, Jane Louisa Debus, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 592-592
Open Access | Times Cited: 14
Polypharmacy in Chronic Neurological Diseases: Multiple Sclerosis, Dementia and Parkinson’s Disease
Niklas Frahm, Michael Hecker, Uwe K. Zettl
Current Pharmaceutical Design (2021) Vol. 27, Iss. 38, pp. 4008-4016
Closed Access | Times Cited: 18
Niklas Frahm, Michael Hecker, Uwe K. Zettl
Current Pharmaceutical Design (2021) Vol. 27, Iss. 38, pp. 4008-4016
Closed Access | Times Cited: 18
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation
Uwe K. Zettl, Paulus Rommer, Orhan Aktaş, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 11, pp. 1343-1359
Open Access | Times Cited: 6
Uwe K. Zettl, Paulus Rommer, Orhan Aktaş, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 11, pp. 1343-1359
Open Access | Times Cited: 6
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis
Michael Hecker, Niklas Frahm, Uwe K. Zettl
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 3-3
Open Access | Times Cited: 6
Michael Hecker, Niklas Frahm, Uwe K. Zettl
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 3-3
Open Access | Times Cited: 6
Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis
Jane Louisa Debus, Paula Bachmann, Niklas Frahm, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13, pp. 204062232211083-204062232211083
Open Access | Times Cited: 10
Jane Louisa Debus, Paula Bachmann, Niklas Frahm, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13, pp. 204062232211083-204062232211083
Open Access | Times Cited: 10
Prevalence, trends, and characteristics of polypharmacy among US pregnant women aged 15 to 44 years: NHANES 1999 to 2016
Yu-Chien Chang, Hsin‐Yi Huang, Tsung‐Hua Shen, et al.
Medicine (2023) Vol. 102, Iss. 22, pp. e33828-e33828
Open Access | Times Cited: 4
Yu-Chien Chang, Hsin‐Yi Huang, Tsung‐Hua Shen, et al.
Medicine (2023) Vol. 102, Iss. 22, pp. e33828-e33828
Open Access | Times Cited: 4
Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies
W. Chapman, Megan C. Herink, Michelle Cameron, et al.
Current Neurology and Neuroscience Reports (2023) Vol. 23, Iss. 9, pp. 521-529
Closed Access | Times Cited: 4
W. Chapman, Megan C. Herink, Michelle Cameron, et al.
Current Neurology and Neuroscience Reports (2023) Vol. 23, Iss. 9, pp. 521-529
Closed Access | Times Cited: 4
Cancer and mortality risks among people with multiple sclerosis: A population-based study in Isfahan, Iran
Amirhossein Nafari, Saeed Vaheb, Alireza Afshari-Safavi, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0312707-e0312707
Open Access
Amirhossein Nafari, Saeed Vaheb, Alireza Afshari-Safavi, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0312707-e0312707
Open Access
Literaturverzeichnis zum Titel: Zettl/Sieb: Diagnostik und Therapie neurologischer Erkrankungen, 6.A. 2024
Elsevier eBooks (2024), pp. e1-e123
Closed Access
Elsevier eBooks (2024), pp. e1-e123
Closed Access
Polypharmazie
Niklas Frahm, Michael Hecker, Uwe K. Zettl
Elsevier eBooks (2024), pp. 659-667
Closed Access
Niklas Frahm, Michael Hecker, Uwe K. Zettl
Elsevier eBooks (2024), pp. 659-667
Closed Access
